National Advisory Hotline 400-8536-777
Add: No. 17, Tianjin North Road, Yantai Development Zone
Copyright © 2020 Yantai Huaxin Biomedical Science and Technology Co., Ltd
Huaxin Biomedical WeChat
Yantai Huaxin Biomedicine Science and Technology Co., Ltd.
Chairman of Chifeng Wanze Pharmaceutical Company visited Huaxin Biology for investigation and cooperation
On the morning of February 25th, Wang Yuan, chairman of "Chifeng Wanze Pharmaceutical Co., Ltd." and his party visited our company. The chairman of Huaxin Biotechnology Li Lelin and the company's senior leaders warmly approached and expressed his appreciation to the arrival of Chairman Wang Yuan and his party. A warm welcome.
Chifeng Wanze Pharmaceutical Co., Ltd. is a comprehensive high-tech pharmaceutical enterprise integrating scientific research and development, production of raw materials, preparations, food, cosmetics, domestic marketing, and international trade; it has chemical raw materials, tablets, and capsules. There are 85 varieties of eight types of dosage forms, including granules, ointments, creams, solutions, and liniments. Among them, there are 7 varieties of raw materials (tosufloxacin tosylate, sodium alginate, nitrendipine, Cimetidine, nicotinic acid Xantinol, aspirin zinc, tripibuton), 78 varieties of preparations; formed the national second-class new drug tosufloxacin tosylate raw materials and preparations, national patent varieties of traditional Chinese medicine preparations ginseng Ointment, pharmaceutical intermediate 3-aminopyrrolidine dihydrochloride and other series products.
In the afternoon, Chairman Wang Yuan and his party, accompanied by Chairman Li Lelin and the company’s senior management, visited the GMP standard workshop and R&D center of Huaxin Biotech. Chairman Wang Yuan recognized Huaxin Biotech’s international advanced equipment and expressed The large investment in research and development is highly appreciated.
Afterwards, the two parties came to the meeting room to have in-depth discussions on deepening cooperation and achieving a win-win development direction. At the meeting, Chairman Wang Yuan said: Shenji Ointment is an OTC (National Medicine Standard B20020541) product of Wanze Pharmaceutical and has a national invention. Patent, it has significant effect on removing chloasma and improving complexion. You must choose a company with strict product quality control, mature production technology, and perfect sales team for cooperation and transformation. Huaxin Bio is just such a mature skin care product. R&D, production and sales enterprises, this will also be an important part of the in-depth cooperation with Huaxin Biotechnology in the future.
Chairman Li Lelin said: Huaxin Biotech attaches great importance to this negotiation. Wanze Pharmaceutical is a drug research and development and production enterprise. The Shenji ointment product has a good effect. Huaxin Bio has advanced equipment and biological efficacy. With the mature research and development technology of skin care products, we will highly combine the functional ingredients of ginseng ointment with skin care products. This will be another "weapon" to open up market segments. The two parties will establish a continuous and stable relationship in future cooperation. , Seek mutual benefit and seek long-term development together!
